Adenine AI
Stats
Documentation
Summaries
Chat
API
Pricing
Sign in
Announcing Adenine AI Chat:
an evidence-grounded germline and somatic genomics assistant for genes, variants, diseases, and tumors.
Try it now.
Stats
Total associations
6699
Unique genes
4252
Unique diseases
3300
Gene–disease association summaries
Back to Open Access Summaries
Gene–Disease Browser
Search gene/disease/HGNC/MONDO or name
Assertion
Any
Definitive
Strong
Moderate
Limited
Disputed
Refuted
Search
Need updated, customized, evidence‑backed summaries?
Get it from the leaders in AI‑powered, evidence‑backed summaries provider.
Contact us
Gene
Disease
Score
Actions
INTS13
(HGNC:20174)
intellectual disability
(MONDO_0001071)
Limited
ASPG
(HGNC:20123)
aspartylglucosaminuria
(MONDO_0008830)
Strong
ABHD4
(HGNC:20154)
anorexia nervosa
(MONDO_0005351)
Limited
TEDC1
(HGNC:20127)
autosomal recessive primary microcephaly
(MONDO_0016660)
Limited
FLVCR2
(HGNC:20105)
Fowler syndrome
(MONDO_0009168)
Definitive
CHURC1
(HGNC:20099)
autism
(MONDO_0005260)
Limited
ZNF408
(HGNC:20041)
exudative vitreoretinopathy
(MONDO_0019516)
Moderate
USP46
(HGNC:20075)
essential tremor
(MONDO_0003233)
Limited
USP36
(HGNC:20062)
premature menopause
(MONDO_0001119)
Limited
ADAM20
(HGNC:199)
Alzheimer disease
(MONDO_0004975)
Limited
PLSCR5
(HGNC:19952)
bipolar disorder
(MONDO_0004985)
Limited
MYORG
(HGNC:19918)
basal ganglia calcification, idiopathic, 1
(MONDO_0024538)
Strong
SCARF2
(HGNC:19869)
van den Ende-Gupta syndrome
(MONDO_0010959)
Strong
MMRN2
(HGNC:19888)
Parkinson disease
(MONDO_0005180)
Limited
GBP5
(HGNC:19895)
ovarian cancer
(MONDO_0008170)
Limited
POU2F3
(HGNC:19864)
psoriasis
(MONDO_0005083)
Limited
TC2N
(HGNC:19859)
von Willebrand disease (hereditary or acquired)
(MONDO_0024574)
Disputed
EPB41L4B
(HGNC:19818)
colorectal cancer
(MONDO_0005575)
Limited
UTP4
(HGNC:1983)
hereditary North American Indian childhood cirrhosis
(MONDO_0011497)
Moderate
TSSK4
(HGNC:19825)
male infertility
(MONDO_0005372)
Limited
Showing 6121–6140 of 6699
Prev
1
…
305
306
307
308
309
…
335
Next
Back to top